ClinicalTrials.Veeva

Menu

Shulman Fasciitis Prevalence Study in Alsace (SHULMAN)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Shulman Fasciitis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Shulman fasciitis or eosinophilic fasciitis (EF) is a rare inflammatory disease, usually benign but disabling, described by Shulman in 1974. The diagnosis is suggested by the clinic, confirmed by MRI and confirmed by histology, there really no published diagnostic criteria validated for this rare disease. The low number of cases reported in the literature reflects the difficulty of studying the epidemiology of this disease, to establish and evaluate therapeutic strategies and to assess prognosis. Work on this subject are few. To our knowledge, no study has previously used to estimate the incidence and prevalence of this disease. Therefore, the investigators want to determine the prevalence of FEs in Alsace in 2016 by a study "capture-recapture" using several independent sources of identification of cases in order to have recent epidemiological data and learn more about this disease.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged over 18 years
  • Patients suffering from fasciitis Shulmande and living in Alsace at 1 January 2016

Exclusion criteria

  • refusal to participate in the study

Trial contacts and locations

1

Loading...

Central trial contact

Lionel Spielmann, MD; Jean SIBILIA, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems